Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist

Por Beeh, Kai M, Beier, Jutta
Publicado em 2010

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol

Por Beier, Jutta, Beeh, Kai M
Publicado em 2011

Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium

Por Beeh, Kai-Michael, Beier, Jutta, Donohue, James F
Publicado em 2012

Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype – a post-hoc analysis of a randomized, double-blind, placebo-controlled clinic...

Por Beeh, Kai-Michael, Beier, Jutta, Candler, Henning, Wittig, Thomas
Publicado no Int J Chron Obstruct Pulmon Dis (2016)

Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase III...

Por Beier, Jutta, Mroz, Robert, Kirsten, Anne-Marie, Chuecos, Ferran, Gil, Esther Garcia
Publicado no Int J Chron Obstruct Pulmon Dis (2017)

Efficacy, safety, and tolerability of once‐daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7‐day, crossover study

Por Beier, Jutta, Fuhr, Rainard, Seoane, Beatriz, Massana, Eric, de Miquel, Gonzalo, Pujol, Helena, Ruiz, Sandrine
Publicado no Pharmacol Res Perspect (2017)

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Ran...

Por Beier, Jutta, Kirsten, Anne-Marie, Mróz, Robert, Segarra, Rosa, Chuecos, Ferran, Caracta, Cynthia, Gil, Esther Garcia
Publicado em 2013

Tolerability and pharmacokinetics of inhaled bimosiamose disodium in healthy males

Por Meyer, Michael, Beeh, Kai-Michael, Beier, Jutta, Beyer, Diana, Aydt, Ewald, Zahlten, Rainer, Jilma, Bernd, Wolff, Gerhard
Publicado em 2007

Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD...

Por Beier, Jutta, van Noord, Jan, Deans, Amanda, Brooks, Jean, Maden, Claire, Baggen, Suus, Mehta, Rashmi, Cahn, Anthony
Publicado em 2012

Abediterol, a novel long-acting β(2)-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patient...

Por Beier, Jutta, Pujol, Helena, Seoane, Beatriz, Jimenez, Eulalia, Astbury, Carol, Massana, Eric, Ruiz, Sandrine, de Miquel, Gonzalo
Publicado no BMC Pulm Med (2016)

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma

Por Erpenbeck, Veit J., Popov, Todor A., Miller, David, Weinstein, Steven F., Spector, Sheldon, Magnusson, Baldur, Osuntokun, Wande, Goldsmith, Paul, Weiss, Markus, Beier, Jutta
Publicado no Data Brief (2016)

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study

Por Chapman, Kenneth R, Beeh, Kai-Michael, Beier, Jutta, Bateman, Eric D, D’Urzo, Anthony, Nutbrown, Robert, Henley, Michelle, Chen, Hungta, Overend, Tim, D’Andrea, Peter
Publicado em 2014

Longitudinal measurement of airway inflammation over one year in children and adults with intermittent asthma

Por Pedersen, Frauke, Holz, Olaf, Kanniess, Frank, Zielen, Stefan, Schulze, Johannes, Gillissen, Adrian, von Berg, Andrea, Berdel, Dietrich, Beier, Jutta, Beeh, Kai, Schnoor, Maike, Magnussen, Helgo
Publicado no BMC Res Notes (2014)